Cyclacel Pharmaceuticals Reviews 2019 Achievements and Announces Key Business Objectives for 2020
13 janv. 2020 07h00 HE
|
Cyclacel
– Anticancer Activity of CYC065 Monotherapy in Patients with MCL1 Amplified Solid Tumors and CYC065-venetoclax combination in AML/MDS and CLL dose escalation studies – BERKELEY HEIGHTS, N.J., Jan. ...
Incysus Therapeutics to Present at Biotech Showcase 2020
09 janv. 2020 07h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2020 in San Francisco
06 janv. 2020 07h00 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Intrommune to Present at Biotech Showcase™ 2020
18 déc. 2019 09h05 HE
|
Intrommune Therapeutics
New York, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics will attend and present at the upcoming Biotech Showcase™, which occurs during the annual J.P. Morgan Biotechnology...
Plus Therapeutics to Present at Biotech Showcase 2020
09 déc. 2019 07h00 HE
|
Plus Therapeutics, Inc.
AUSTIN, Texas, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced that it has scheduled a company presentation at Biotech Showcase 2020, to be...
CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational
30 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD...
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
09 janv. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the...
Cyclacel Pharmaceuticals Reviews 2018 Achievements and Announces Key Business Objectives for 2019
07 janv. 2019 07h00 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Auransa to Present at Biotech Showcase 2019
02 janv. 2019 08h05 HE
|
Auransa
PALO ALTO, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Aptose Biosciences to Present at Biotech Showcase™ 2019 Conference
02 janv. 2019 07h05 HE
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...